Abstract:To detect effects of B7 co-stimulation on cytokines, especially on IL-2 mRNA and transcription factors NF-kappa B and AP-1, antiB7-1 McAb, antiB7-2 McAb and C TLA-4 Ig were added into mixture lymphocyte reaction (MLR) system to block B7/C D28 signal transduction, IL-2 mRNA and IL-4 mRNA were determined by using competitive PCR and IFN-gamma mRNA by using semi-quantitative PCR. MHC class II molecules and B7 transfectants were used to stimulate CD28(+) T cell, effects of B7 on NF-kappa B and AP-1 were detected by DNA-protein binding assay. The results showed that IL-2, IL-4 and IFN-gamma mRNA were significantly lower when blockade of B7-2 in MLR than blockade of B7-1. Synergistic effects could be seen with combination of two or three antibodies. One to six hours after MLR, tDR7 alone induced NF-kappa B binding activity; cotransfecting B7 no significantly difference at early time point. After 6 hours, induction of tDR7 was decreased whereas B7 prolonged the induction of NF-kappa B till 72 hours. tDR7 alone also upregulated AP-1 binding activity, on the contrary to NF-kappa B, co-transfecting B7-1 and B7-2 decreased AP-1 binding activity within 24 hours. But during 48 - 72 hours, B7 also prolonged the AP-1 binding activity. It is concluded that after MLR, B 7 increased IL-2 secretion by decreasing the degradation of IL-2 mRNA and upregulating IL-2 transcription factors. B7 also induced several kinds of cytokines secretion. Effects of B7-1 and B7-2 had no significant difference on transcription factors. It is suggested that the different functions between B7-1 and B7-2 maybe related to the difference of cell expression and kinetics. To study the molecular mechanism of B7 mediated T cell immune tolerance can help us to design a better clinic schema to prevent transplantation rejection and GVHD.

Study on the Role of B7 Mab in Blocking the Pathway of B7/CD28 in Xeno-celluar Immune Response in Vitro

Experimental Study of the Therapeutic Effectiveness and Mechanism of Bispecific HER2 × CD3 Antibodies to HER2-overexpressing Xenografts in Nude Mice

[The Identical Effects of B7-1 and B7-2 on Regulation of Human IL-2 Gene Transcription Factors NF-kappa B and AP-1].

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

Functional Expression of B7H1 on Pancreatic Carcinoma Panc-1 Cells

Study on the Mechanism Underlying the Immunosuppression Induced by B7H1-Ig Fusion Protein

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

The suppressor T cells induced by membranous B7-H1 molecule and their immunobiological properties

The role of B7 molecules in T cell anergy

B7-H1 enhances Ag-specific lymphocytes proliferation and induces immunosuppressive T cells

Assessment Of Re-188 Marked Anti Mhc Class Ii Antibody By Peripheral Blood Mononuclear Cells Stimulated By Donor Alloantigen

B7-H4 expression in various tumors determined using a novel developed monoclonal antibody

Experimental study on enhancement of immune function of dendritic cells from peripheral blood of patients with bladder cancer by blocking the B7-H1 pathway

The Study on the Relationship Between Expression of B7-H1 on HBV Transgenic Mice and Immune Toler-Ance to HBV

The experimental study on antitunor effect of B7-1 gene modified murine EL-4 cells vaccine

Effect of Mycophenolic Acid on T Lymphocyte Proliferation and Cytokine Expression in Vitro

Aberrant Expression of B7-H4 and BTLA in Tumor Model

B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.

Clinical significance of B7-H3 expression in circulating CD4+CD25high T cells, CD14+ monocytes, and plasma for the progression of HIV infection

Antitumor Effects Induced by B7-1 Gene Modified EL-4 Lymphoma Cooperated with IL-2in Vivo Andin Vitro

Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function